LXS196
CAS No. 1874276-76-2
LXS196( —— )
Catalog No. M20328 CAS No. 1874276-76-2
LXS196 is a potent selective and orally active protein kinase C (PKC) inhibitor(IC50 values of 1.9 nM 0.4 nM and 3.1 μM for PKCα PKCθ and GSK3β respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 138 | In Stock |
|
| 5MG | 131 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 351 | In Stock |
|
| 50MG | 492 | In Stock |
|
| 100MG | 724 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLXS196
-
NoteResearch use only, not for human use.
-
Brief DescriptionLXS196 is a potent selective and orally active protein kinase C (PKC) inhibitor(IC50 values of 1.9 nM 0.4 nM and 3.1 μM for PKCα PKCθ and GSK3β respectively).
-
DescriptionLXS196 is a potent selective and orally active protein kinase C (PKC) inhibitor(IC50 values of 1.9 nM 0.4 nM and 3.1 μM for PKCα PKCθ and GSK3β respectively).
-
In Vitro——
-
In VivoAnimal Model:Mice implanted with 92.1 GNAQ mutant uveal melanoma cells.Dosage:15, 30, 75, 150 mg/kg Administration:P.O. (bid) for 35 days Result:Dose-dependently suppressed the tumor growth.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorPKC
-
Research AreaCancer
-
IndicationColorectal Cancer; Malignant melanoma; Solid tumours; Uveal melanoma
Chemical Information
-
CAS Number1874276-76-2
-
Formula Weight472.47
-
Molecular FormulaC22H23F3N8O?
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (211.65 mM)
-
SMILESCC1(N)CCN(CC1)c1cccnc1NC(=O)c1nc(cnc1N)-c1ncccc1C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Protein Kinase C Inhibitor LXS196.
molnova catalog
related products
-
Coptisine chloride
Coptisine chloride can be absorbed across intestinal epithelial cells, and completely absorbed compounds.
-
Sotrastaurin
A potent, selective, orally available pan-PKC inhibitor with Ki of 0.22-3.2 nM for PKC isotypes.
-
Sodium aurothiomalat...
Sodium aurothiomalate is a gold compound that is used for its immunosuppressive anti-rheumatic effects.
Cart
sales@molnova.com